Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

EM case files > tachycardia, DKA, sepsis > Flashcards

tachycardia, DKA, sepsis Flashcards

1
Q

As a general rule, narrow-QRS complex tachycardias arise from ? while wide-QRS complex ones may be ? in origin

A

narrow: above the ventricles (SVT)

wide (0.12+): supraventricular or ventricular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

regular rhythms with narrow QRS

A 
Sinus tachycardia
Atrial tachycardia
AV nodal reentrant tachycardia (AVNRT)
AV reentrant tachycardia (AVRT)
Junctional tachycardia
Atrial flutter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

regular rhythms with wide QRS

A

V tach
Antidromic AVRT
Narrow complex tachycardia with aberrancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

irregular rhythms with narrow QRS

A

Atrial flutter with variable block
Afib
Multifocal atrial tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

irregular rhythms with wide QRS

A

Polymorphic Vtach

Narrow complex tachycardia with aberrancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If the tachycardic patient is unstable (as evidenced by ?), ? should be performed immediately

A

hypotension, pulmonary edema, AMS, or ischemic chest pain

synchronized cardioversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In stable tachycardic patients, what should be done?

A

12-lead ECG should be obtained, and medical therapy can be initiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

important hx to get in tachy pts

A

time/circumstances surrounding symptom onset, duration of symptoms
PMHx: history of CAD, CHF, dysrhythmia, valvular disease, thyroid disease
current meds (including herbal or homeopathic regimens, OTC meds, and illicit drugs)
Fam hx: sudden cardiac death, dysrhythmia, other types of heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

physical exam in tachy pt may reveal underlying cause i.e.

A

pale mucous membranes with anemia; thyromegaly or goiter with thyrotoxicosis, barrel chest or nail clubbing with chronic lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vtach may be difficult to distinguish from ?

A

SVT with aberrant conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Certain factors favor VT, including ?

A

age 50+, history of CAD or CHF, history of VT, AV dissociation, fusion beats, QRS 0.14+ second, extreme left axis deviation, and precordial concordance (QRS complexes either all positive or all negative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

certain factors suggest SVT with aberrancy

A

age less than 35, history of SVT, preceding ectopic P waves with QRS complexes, QRS less than 0.14 second, normal or almost normal axis, and slowing or cessation of the arrhythmia with vagal maneuvers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If cannot distinguish between VT and SVT with aberrancy with certainty, how should you treat the pt?

A

as if VT is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

other tests to get in tachycardia

A

CXR: chamber enlargement, cardiomegaly, pulmonary congestion or edema
BMP: r/o electrolyte abnormalities that predispose to tachyarrhythmias (eg, hypokalemia, hypocalcemia, hypomagnesemia)
possibly:
thyroid function studies (for hyperthyroidism) drug levels (eg, digoxin) or UDS (for cocaine, methamphetamines, other stimulants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potential interventions for regular narrow-complex tachyarrhythmias

A

vagal maneuvers (such as carotid massage and Valsalva)- will not terminate tachyarrhythmias that do not involve the AV node, but may slow the rate enough to unmask the underlying rhythm abnormality adenosine, B-blockers, and CCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stable patients with regular wide-complex tachycardias may benefit from ?
Second-line therapy for stable patients with monomorphic VT is ?

A

amiodarone, procainamide, or sotalol
(don’t need if non- sustained VT)

lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AV nodal blocking maneuvers

A

Valsalva, diving reflex, and carotid massage

they act through the parasympathetic nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

typical labs in moderate DKA

A

glucose: 500-700
Na+: 130 K+: 4-6
HCO3-: 6-10
BUN: 20-30 pH: 7.1 PCO2: 15-20 (compensating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

typical labs in severe DKA

A 
glucose: 900+
Na+: 125   K+: 5-7
HCO3-: less than 5
BUN 30+  pH: 6.9
PCO2: less than 20 (resp. failure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

DKA dx based on triad of

A

hyperglycemia, ketosis, and metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what other states present with elevated serum ketones?

how to ddx from DKA

A

starvation, pregnancy, alcoholic ketoacidosis, and various toxic ingestions (isopropyl alcohol ingestion)
glucose is normal/low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

DKA triggers

most common?

A

infection is most common! (UTI)
pancreatitis, MI, stroke, and many drugs including corticosteroids, thiazides, sympathomimetics including cocaine, and some antipsychotic drugs
voluntary cessation of insulin (in kids/y. adults)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

massive fluid deficits in DKA, how to tx?

A

often up to 5-10L

adults: 2L bolus of NS
kids: 20 mL/kg of NS
- reverse shock with NS, and then continue an infusion of 1/2 NS at 2-3x maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how to give insulin in DKA

A

regular insulin by continuous IV infusion (0.1 U/kg/hr - about 5-10 U/h in adult)
(IV boluses work ok in adults, not for kids)
-will lower glucose faster than clearing ketones BUT continue insulin until anion gap has narrowed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when to add dextrose in DKA?

A

when glucose falls to 200-300 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

HCO3- in DKA?
complications?
when is it important to give

A

studies have failed to show improvements with treatment

complications: hypernatremia, hypokalemia, paradoxical CSF acidoses, systemic alkalosis
* lifesaving in hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

leading cause of morbidity and mortality in pediatric DKA

A

cerebral edema

  • due to development of cryptogenic osmoles in the CNS to counter dehydration, which then draw water intracellularly during treatment (unproven)
  • associated with overhydration and vigorous insulin therapy
  • only reliable predictor of cerebral edema is the severity of metabolic derangements at presentation
  • still important to reverse shock
28
Q

most common causes of severe sepsis

A

urosepsis and pneumonia

29
Q

Older, younger, or immunocompromised individuals with sepsis may present with subtle signs such as ?

A

lethargy, decreased appetite, or hypothermia

30
Q

Early goal-directed therapy for sepsis includes ?

A

careful monitoring of multiple markers of organ perfusion, with aggressive measures to restore any imbalance between oxygen supply and demand

31
Q

4 goals of sepsis treatment

A

fluids
discover source
then tx with abx
pressors: NE, dopamine

32
Q

SIRS criteria

A

Temperature 38°C+ or less than 36°C
HR 90+ bpm
Tachypnea or hyperventilation (RR 20+ or Paco2 less than32 mm Hg)
WBC 12,000+ cells/mL or less than 4000 cells/mL, or more than 10% bands

33
Q

Severe sepsis

A

sepsis + at least one sign of organ failure or hypoperfusion, such as lactic acidosis (lactate 4+ mmol/L), oliguria (urine output less than 0.5 mL/kg for 1 hour), abrupt change in mental status, mottled skin or delayed capillary refill, thrombocytopenia (platelets less than 100,000 cells/mL) or DIC, or acute lung injury/ARDS

34
Q

Septic shock

A

Severe sepsis with hypotension (or requirement of vasoactive agents, eg, dopamine or NE) despite adequate fluid resuscitation in the form of a 20- to 40-cc/kg bolus

35
Q

sepsis suspects if unknown source

A 
Escherichia coli
Staphylococcus aureus
Streptococcus pneumoniae
Enterococcus spp
Klebsiella spp
Pseudomonas aeruginosa
36
Q

how to tx sepsis with unknown source

A

vanc and zosyn OR
antipseudomonal cephalosporin (eg, ceftazadine, cefepime) + FQ (levofloxacin, ciprofloxacin) OR
aminoglycoside (eg, gentamicin, amikacin)

37
Q

pneumonia suspects

A 
Streptococcus pneumoniae
Mycoplasma pneumoniae
Haemophilus influenza,
Chlamydophila pneumoniae
Legionella
38
Q

how to tx pneumonia

A

Antipseudomonal cephalosporin (eg, ceftazadine, cefepime) + macrolide (eg, azithromycin)
Or
FQ (eg, levofloxacin, moxifloxacin)

39
Q

UTI suspects

A

Escherichia coli
Klebsiella spp
Enterococcus spp

40
Q

how to tx UTI

A

FQ (eg, levofloxacin)
Or
third-generation cephalosporin (eg, ceftriaxone)

41
Q

meningitis suspects

A

Streptococcus pneumoniae
Neisseria meningitides
Listeria monocytogenes (primarily in adults over 50-60 or immunocompromised patients)

42
Q

meningitis tx

A

Vanc +

ceftriaxone + Ampicillin if listeria is suspected

43
Q

how to tx abdominal infections

A

Ampicillin +
aminoglycoside (eg, gentamicin, amikacin) +
metronidazole

44
Q

devastating effects in sepsis caused by

A

(1) generalization of the immune response to sites remote from that of the infection (vasodilation and coagulation—>hypotension, hypoperfusion, coagulopathy, and resultant organ failure)
(2) derangement of the balance between proinflammatory and anti-inflammatory cellular regulators
(3) dissemination of the infecting organism

45
Q

what correlates strongly with prognosis in sepsis?

A

higher presenting lactate levels and slow decline of lactate during resuscitation are associated with significantly higher mortality

46
Q

initial sepsis management

A

supplemental O2 to keep above 93%
Two large-bore IVs
Lactic acid
Initial fluid bolus of 20-40 mL/kg or 2-4 L in adults
CBC
CMP
Blood cultures from two sites (ideally before abx)
Urinalysis with culture
Pregnancy test in women of childbearing age
CXR
Empiric antibiotics (goal is less than 1 h from initial presentation)

47
Q

reassess septic pt after first fluid bolus

A

if continues to be hypotensive or has a lactate level greater than 4 mmol/dL or has other signs of continued hypoperfusion, then early goal-directed therapy (EGDT) should be initiated

48
Q

Goal 1 of EGDT

A

CVP 8-12 mm Hg or 12+ if mechanically vented
500 cc of normal saline can be bolused every 15 to 30 minutes until the CVP goal is met
(may be 6-10 L over 1st hours)

49
Q

Goal 2 of EGDT

A

MAP +65 mm Hg

if remains below despite adequate resuscitation, add NE (levophed) or dopamine, low dose vasopressin as 2nd/3rd line

50
Q

Goal 3 of EGDT

A

central venous oxygen saturation (ScvO2) 70%+
if not met, optimize O2 delivery by:
-transfuse PRBCs 30%+
-if HCT up to 30%+, and other 2 goals met and SVC dobutamine
-then: intubate to maximize oxygenation and sedate to reduce O2 demand

51
Q

Additional goal of EGDT

A

lactate clearance 10%+
recheck 2 hrs after initiating fluid resuscitation; if 10% not cleared, optimize O2 as in goal 3
lactate can be used in lieu of ScvO2 monitoring

52
Q

how to monitor severely septic/septic shock pt

A

in ICU; measure BP, CVP, O2 sat, central venous sat, UOP, lactate

53
Q

Ultrasound in sepsis

A

can be used to monitor CVP that does not require placement of a central venous catheter
-compression US of the forearm or measurement of the internal jugular vein to approximate CVP

54
Q

steroids in sepsis?

A
  • do not improve mortality
  • not recommended that they be used in sepsis without shock unless there is a recent history of prolonged steroid use or history suggesting adrenal suppression
  • may be considered in septic shock unresponsive to fluid resuscitation and vasopressors
55
Q

activated protein C in sepsis?

A

an enzyme produced in the liver that inhibits thrombosis and promotes fibrinolysis. A patient’s native ability to activate protein C appears to be impaired in sepsis

  • it should only be given to patients with sepsis-induced organ dysfunction that are deemed to be at a high risk of death
  • never in kids of if CIs to anticoags
56
Q

glucose goal in sepsis

A

between 140 and 180 mg/dL

used to be 80 to 120 mg/dL but this cause more cases of hypoglycemia

57
Q

IVIG in sepsis?

A

improved mortality in neonates/children, recently inconclusive
mechanism: augmented clearance of pathogenic organisms and feedback inhibition of inflammatory cytokines

58
Q

ECMO in sepsis?

A

Extracorporeal membrane oxygenation (ECMO), a form of mechanical heart-lung bypass
-inconclusive; may be tried in pt with cardiorespiratory failure that is refractory to traditional means of support

59
Q

statins in sepsis?

A

being on a statin lowers human patients’ likelihood of death from sepsis

60
Q

sepsis complications

A 
ALI/ARDS
DIC
cardiac failure
hepatic failure 
renal failure 
multi organ dysfunction syndrome
61
Q

ALI/ARDS can be seen in sepsis due to

A

Buildup of inflammatory fluid in the alveoli impairs gas exchange favors lung collapse, and decreases compliance, with the end result of respiratory distress and hypoxemia

  • bilateral pulmonary opacities consistent with pulmonary edema, may develop after fluid resuscitation
  • may require mechanical ventilation; use low tidal volumes and limit PEEP
62
Q

DIC in sepsis due to

A

coagulation cascade activated as well as fibrinolytic system- new clots always being formed, then broken down, clotting factors and plts being consumed, at risk for complications from both thrombosis and hemorrhage
give platelets if count is less than 5000 cells/mm3 without signs of bleeding, or less than 30,000 cells/mm3 with active bleeding (+FFP if bleeding)

63
Q

cardiac failure in sepsis due to

A

direct action of inflammatory molecules, monitor preload (hydration and CVP monitoring), after load (pressers), and contractility (dobutamine)
-take caution when giving pressors/inotropes to elderly as may induce tachycardia–>increased workload–>acute coronary syndrom

64
Q

hepatic failure in sepsis manifests as

A

cholestatic jaundice, with increases in bilirubin, aminotransferases, and alkaline phosphatase, synthetic function usually not affected

65
Q

main cause of renal failure in sepsis?
manifests how?
how to tx, and if refractory?

A

Hypoperfusion
oliguria, azotemia, and inflammatory cells on urinalysis
adequately support perfusion with hydration and vasopressors
if still not perfusing, renal replacement therapy (eg, hemodialysis or continuous veno-venous hemofiltration) is indicated

66
Q

multiorgan dysfunction syndrome

A

Dysfunction of two or more organ systems such that intervention is required to maintain homeostasis

primary: i.e. heart/lung failure in pneumonia (direct injury)
secondary: i.e. ALI/ARDS in urosepsis (generalized inflammatory response)

EM case files (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions